Searched for
DAIICHI PHARMACEUTICAL
Tokyo Court to rule on Fortis arm IHH and Daiichi Sankyo disputeA significant legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. The Tokyo District Court will announce its jud...29 Apr, 2026, 12.20 AM IST- IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...29 Apr, 2026, 12.06 AM IST
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...27 Apr, 2026, 02.24 PM IST
- The CEO who capped a $37 billion recovery with AstraZeneca dealNakayama decided to reboot Daiichi Sankyo, pivoting toward the more lucrative business of cancer drugs.06 Aug, 2019, 06.15 PM IST
- Sun Pharma shares bounce back, up nearly 2% at closeThe stock jumped 2.84 per cent during the day trade before settling 1.63 per cent higher at Rs 967.15 on BSE. At the NSE, the scrip gained ...22 Apr, 2015, 06.24 PM IST
- Daiichi Sankyo chairman Takashi Shoda, who led its Ranbaxy buy, steps downShoda was Daiichi’s CEO when it bought a controlling stake in Ranbaxy six years ago for $4.6 billion, which was the largest deal in pharma ...16 May, 2014, 04.35 PM IST
- Market gives a thumbs-up to Ranbaxy deal; Sun Pharma and Daiichi Sankyo gainShares of Sun Pharma surged 2.68 per cent or Rs 15.35 to close at Rs 587.25 as the all-share deal’s swap ratio is seen to favour investors ...08 Apr, 2014, 04.26 AM IST
- Sun Pharma-Ranbaxy deal: Daichi Sankyo failed to harness the complexities of a strong generic business, says Malvinder SinghThe Sun-Ranbaxy combined entity will unlock the true potential of the Gurgaon based company, says former Ranbaxy owner Malvinder Singh.07 Apr, 2014, 09.37 AM IST
- Ranbaxy, Daiichi Sankyo to collaborate in Brazil to expand businessIn Brazil, Daiichi Sankyo has built up its market presence with innovative pharmaceuticals through Daiichi Sankyo Brazil.18 Apr, 2013, 04.00 AM IST
- Ranbaxy, Daiichi Sankyo to leverage synergies in ThailandRanbaxy Laboratories and its Japanese parent Daiichi Sankyo to integrate their business operations in Thailand to maximise synergies.16 Jan, 2013, 01.37 PM IST
- Daiichi Sankyo and Ranbaxy Launch hybrid business in VenezuelaDaiichi Sankyo & Ranbaxy announced that Daiichi Sankyo Venezuela would begin marketing Ranbaxy products in Venezuela as part of hybrid busi...20 Jun, 2012, 03.55 PM IST
- Glenmark settles patent infringement litigation with Daiichi, GenzymeThe company has received a licence from Daiichi Sankyo and Genzyme that will permit it to launch its generic Colesevelam Hydrochloride prod...04 Jul, 2011, 02.22 PM IST
- Daiichi acquires 20% from Ranbaxy promoters, hikes stake to over 50%Ranbaxy is now a subsidiary of Japanese drug major Daiichi Sankyo.21 Oct, 2008, 01.02 AM IST
- Daiichi Sankyo acquires 52.5% stake of RanbaxyThe board of directors at Ranbaxy Laboratories approved the allotment of equity shares and warrants on a preferential basis to Daiichi Sank...20 Oct, 2008, 04.04 PM IST
- Govt to seek room for drug firms in JapanEndorsing the Daiichi-Ranbaxy deal, the Indian government is planning to make the most of it in its bilateral trade and investment pact bei...14 Jun, 2008, 12.13 AM IST
- Ranbaxy sees bright future in ageing JapanThe head of India's generic drug leader Ranbaxy sees a bright future in Japan as its population gets older.12 Jun, 2008, 05.45 PM IST
- Daiichi buys promoter stake in Ranbaxy at Rs 737 per shareJapanese drugmaker Daiichi Sankyo has bought entire 35 per cent promoters stake in Ranbaxy Laboratories at Rs 737 per share.11 Jun, 2008, 12.39 PM IST
Load More
